Rayner Announces Full Commercial Launch of RayOne Galaxy and RayOne Galaxy Toric
After unveling the RayOne Galaxy and RayOne Galaxy Toric IOLs at the ESCRS congress in Barcelona, Rayner announced the full commercial release of the IOLs today. The launch comes following a large-scale multicentre data collection study, Rayner said.
Developed with AI, the RayOne Galaxy's unique non-diffractive spiral optic is designed to deliver a smooth and continuous full range of vision with minimized dysphotopsia and 0% loss of transmitted light.*
According to Rayner, 10 surgeons from 10 countries conducted a pre-launch clinical evaluation, with over 180 eyes treated with RayOne Galaxy and RayOne Galaxy Toric–collecting postoperative clinical outcomes at 1 and 3 months. Interim outcomes show that RayOne Galaxy and RayOne Galaxy Toric provide:
- A full range of vision, without the wave-like defocus pattern associated with diffractive trifocal IOLs
- Mean corrected and uncorrected visual acuities at all distances of 0.1 logMAR or better*
- Binocular defocus curve VA of 0.2 logMAR or better across a ~4.0 D range*
- Less halo and glare compared to published data on diffractive trifocal IOLs
- In a preclinical study of 30 subjects with healthy eyes, RayOne Galaxy demonstrated a halo size closer to that of an enhanced monofocal IOL than a diffractive trifocal IOL.**
Between October and December 2024, RayOne Galaxy and RayOne Galaxy Toric have been available in a limited release phase to selective surgeons, allowing Rayner to collect further valuable insights before the full commercial release.
The RayOne Galaxy spiral IOL platform is now available to all surgeons, subject to local regulatory approval. For more information, visit www.rayner.com/Galaxy. To view EyewireTV's coverage of the launch of the RayOne Galaxy, click here.